These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8927264)

  • 41. Effect of doxazosin on the left ventricular structure and function in morning hypertensive patients: the Japan Morning Surge 1 study.
    Matsui Y; Eguchi K; Shibasaki S; Ishikawa J; Hoshide S; Pickering TG; Shimada K; Kario K
    J Hypertens; 2008 Jul; 26(7):1463-71. PubMed ID: 18551024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of enalapril on left ventricular mass and performance in essential hypertension.
    Grandi AM; Venco A; Barzizza F; Casadei B; Marchesi E; Finardi G
    Am J Cardiol; 1989 May; 63(15):1093-7. PubMed ID: 2539714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients.
    Martínez Castelao A; Ibernón M; Sarrias X; Sanz V; Moreso F; Rama I; Grinyó JM
    Transplant Proc; 2003 Aug; 35(5):1736-8. PubMed ID: 12962776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How hypertension redevelops after cessation of long-term therapy.
    Jennings GL; Korner PI; Laufer E; Esler MD; Burton D; Bruce A
    J Hypertens Suppl; 1984 Dec; 2(3):S217-9. PubMed ID: 6599672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Doxazosin (Carduran)--a research survey].
    Stokke HP; Fauchald P; Holme I; Rugstad HE; Christophersen BO; Stokke O
    Tidsskr Nor Laegeforen; 1993 Feb; 113(6):693-9. PubMed ID: 8465331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and availability of doxazosin in treating hypertensive patients with chronic renal failure.
    Mori Y; Matsubara H; Nose A; Shibasaki Y; Masaki H; Kosaki A; Okigaki M; Fujiyama S; Tanaka-Uchiyama Y; Hasegawa T; Iba O; Tateishi E; Amano K; Iwasaka T
    Hypertens Res; 2001 Jul; 24(4):359-63. PubMed ID: 11510747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of administration and withdrawal of doxazosin on ambulatory blood pressure in patients with essential hypertension.
    Takata Y; Yoshizumi T; Ito Y; Hirota Y; Fujishima M
    Angiology; 1995 Jan; 46(1):11-8. PubMed ID: 7818152
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Echocardiographic assessment of doxazosin on left ventricular mass in patients with essential hypertension.
    Monsalve P; Vera O; Pérez Acuña F; Medina O; Ostojich K; López B; Torres N; Lugo de Franco V; Fonseca R
    Am Heart J; 1991 Jan; 121(1 Pt 2):356-61. PubMed ID: 1824661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of doxazosin as the third agent on morning hypertension and position-related blood pressure changes in diabetic patients with chronic kidney disease.
    Yasuda G; Saka S; Ando D; Hirawa N
    Clin Exp Hypertens; 2015; 37(1):75-81. PubMed ID: 24866870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Doxazosin in the treatment of mild or moderate essential hypertension: an echocardiographic study.
    Corral JL; López NC; Pecorelli A; Rincón LA; Terán VD
    Am Heart J; 1991 Jan; 121(1 Pt 2):352-6. PubMed ID: 1824660
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Doxazosin to treat hypertension: it's time to take it personally--a retrospective analysis of 19, 495 patients.
    Wolak T; Toledano R; Novack V; Sharon A; Shalev A; Wolak A
    J Hypertens; 2014 May; 32(5):1132-7; discussion 1137. PubMed ID: 24509125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical application of wave intensity for the treatment of essential hypertension.
    Fujimoto S; Mizuno R; Saito Y; Nakamura S
    Heart Vessels; 2004 Jan; 19(1):19-22. PubMed ID: 14685750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Determinant of left ventricular hypertrophy in the hypertensive woman. Influence of hormone replacement therapy for menopause].
    du Cailar G; Ribstein J; Pasquié JL; Mimran A
    Arch Mal Coeur Vaiss; 1999 Aug; 92(8):975-7. PubMed ID: 10486649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and efficacy of doxazosin as an "add-on" antihypertensive therapy in mild to moderate heart failure patients.
    Spoladore R; Roccaforte R; Fragasso G; Gardini C; Palloshi A; Cuko A; Arioli F; Salerno A; Margonato A
    Acta Cardiol; 2009 Aug; 64(4):485-91. PubMed ID: 19725441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term efficacy of doxazosin plus atenolol in the management of severe and sustained arterial hypertension and reversibility of the cardiac damage induced by chronic cathecolamine excess. A case report in a young girl with recurrent, functioning paraganglioma.
    Pulcrano M; Palmieri EA; Pagano L; Tauchmanova L; Rossi A; Fazio S; Lombardi G; Biondi B
    J Endocrinol Invest; 2004 Sep; 27(8):774-7. PubMed ID: 15636433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiovascular and renal effects of long-term antihypertensive treatment.
    Hartford M; Wendelhag I; Berglund G; Wallentin I; Ljungman S; Wikstrand J
    JAMA; 1988 May; 259(17):2553-7. PubMed ID: 3357228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The antihypertensive effects of doxazosin on the arterial system: changes in peripheral vascular resistance and wall tension.
    Karter Y; Aran S; Seyahi N; Tunçkale A; Yaldiran A; Sipahioglu F; Öztürk E
    Eur J Intern Med; 2000 Jun; 11(3):140-144. PubMed ID: 10854819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between cardiac function and the sympathetic nervous system during exercise in patients with essential hypertension.
    Yasuda M; Nishikimi T; Akioka K; Teragaki M; Oku H; Takeuchi K; Takeda T; Naka K; Okuda K; Ikuno Y
    Jpn Circ J; 1988 Oct; 52(10):1121-31. PubMed ID: 3210290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating microRNA-133a in Patients With Arterial Hypertension, Hypertensive Heart Disease, and Left Ventricular Diastolic Dysfunction.
    Koval SM; Snihurska IO; Yushko KO; Mysnychenko OV; Penkova MY; Lytvynova OM; Berezin AE; Lytvynov VS
    Front Cardiovasc Med; 2020; 7():104. PubMed ID: 32733920
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cognitive Impairment in Postmenopausal Women With Arterial Hypertension].
    Larina VN; Bart BY; Gardanova ZR; Runikhina NK
    Kardiologiia; 2015 Jan; 55(1):33-36. PubMed ID: 28294824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.